Roy D. Baynes - Insider Trading & Ownership

Location
C/O Retrophin, Inc., 12255 El Camino Real, Suite 250, San Diego, CA
Summary
The estimated net worth of Roy D. Baynes is at least $4.83M dollars as of November 21, 2025. Roy D. Baynes is the Director of Natera, Inc. and owns shares of Natera, Inc. (NTRA) stock worth about $4.13M. Roy D. Baynes is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $687K. Roy D. Baynes is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $16.9K.
Signature
/s/ Vincent Fontanilla, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Roy D. Baynes

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NTRA Natera, Inc. Director $4.13M -$2.81M -40.5% Nov 19, 2025
TVTX Travere Therapeutics, Inc. Director $687K -$540K -44% May 15, 2025
ATRA Atara Biotherapeutics, Inc. Director $16.9K Jun 23, 2022
AARD Aardvark Therapeutics, Inc. Director Jun 11, 2025
NRIX Nurix Therapeutics, Inc. Director May 19, 2025

Insider Transactions Reported by Roy D. Baynes:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.